Published in Hum Mol Genet on January 01, 1995
Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A (1996) 3.18
BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1997) 2.55
BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol (2004) 2.46
Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol (1997) 2.40
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet (1997) 2.33
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A (2001) 1.90
BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A (1998) 1.81
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med (2011) 1.79
Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet (1996) 1.56
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. BMC Cancer (2015) 1.38
Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet (1997) 1.27
Breast cancer risk and environmental exposures. Environ Health Perspect (1997) 1.23
Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation. Cancer Res (2000) 1.21
BRCA1 variants in a family study of African-American and Latina women. Hum Genet (2005) 1.19
Protein disorder in the human diseasome: unfoldomics of human genetic diseases. BMC Genomics (2009) 1.11
Screening for 185delAG in the Ashkenazim. Am J Hum Genet (1997) 1.04
A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer. PLoS One (2014) 0.99
Targeting signaling pathways in epithelial ovarian cancer. Int J Mol Sci (2013) 0.98
Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet (1996) 0.96
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep (2011) 0.95
RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance. J Clin Invest (2016) 0.94
Ethnic differences in cancer incidence: a marker for inherited susceptibility? Environ Health Perspect (1997) 0.93
Association of common ATM variants with familial breast cancer in a South American population. BMC Cancer (2008) 0.92
Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1. Mutat Res (2008) 0.91
BRCA1 and BRCA2 mutations in central and southern Italian patients. Breast Cancer Res (2000) 0.88
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin. Cancer Res (2016) 0.87
Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer. PLoS One (2012) 0.87
Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival. Br J Cancer (1999) 0.80
PCR-SSCP-HDX analysis of pooled DNA for more rapid detection of germline mutations in large genes. The BRCA1 example. Nucleic Acids Res (1996) 0.79
Statins and Breast Cancer: Future Directions in Chemoprevention. Curr Breast Cancer Rep (2013) 0.78
An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews. Br J Cancer (1998) 0.78
Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis. Dis Model Mech (2016) 0.77
BRCA1 partially reverses the transforming activity of the ras oncogene. Neoplasia (1999) 0.75
Genetic diversity and disease susceptibility. Philos Trans R Soc Lond B Biol Sci (1997) 0.75
The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"? PLoS One (2017) 0.75
Gene-based segregation method for identifying rare variants in family-based sequencing studies. Genet Epidemiol (2017) 0.75
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis (2017) 0.75
Evolution at two levels in humans and chimpanzees. Science (1975) 21.07
Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet (1994) 4.15
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat Struct Biol (2001) 4.15
Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A (1988) 4.02
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. Am J Hum Genet (1986) 3.83
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation (1990) 3.83
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Population genetics of BRCA1 and BRCA2. Am J Hum Genet (1997) 3.28
Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science (1997) 3.21
Detecting linkage for genetically heterogeneous diseases and detecting heterogeneity with linkage data. Am J Hum Genet (1986) 3.16
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet (2001) 2.98
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res (1996) 2.91
Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA (1998) 2.76
Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia (1987) 2.44
Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst (1985) 2.43
Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science (1998) 2.42
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet (1993) 2.37
Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. J Natl Cancer Inst (1983) 2.21
Insights into the functions of BRCA1 and BRCA2. Trends Genet (2000) 2.10
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A (2001) 1.90
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet (1994) 1.88
A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes. Am J Hum Genet (1991) 1.86
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res (1995) 1.85
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease. Am J Hum Genet (1992) 1.71
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet (1996) 1.69
Identifying individuals by sequencing mitochondrial DNA from teeth. Nat Genet (1992) 1.64
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet (1997) 1.60
Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet (1991) 1.57
Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1. J Biol Chem (1999) 1.57
Genetic information and the workplace: legislative approaches and policy changes. Science (1997) 1.56
Social structuring of mammalian populations and rate of chromosomal evolution. Proc Natl Acad Sci U S A (1975) 1.52
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer (2000) 1.51
BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions. J Biol Chem (2001) 1.50
The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain. J Biol Chem (1998) 1.46
Male influences on cervical cancer risk. Am J Epidemiol (1986) 1.46
Familial breast cancer in a population-based series. Am J Epidemiol (1986) 1.44
Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol (1987) 1.43
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet (1988) 1.42
The gene for an inherited form of deafness maps to chromosome 5q31. Proc Natl Acad Sci U S A (1992) 1.42
Call for a worldwide survey of human genetic diversity: a vanishing opportunity for the Human Genome Project. Genomics (1991) 1.34
Heterogeneity analysis of breast cancer families by using age at onset as a covariate. Am J Hum Genet (1992) 1.33
Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet (1991) 1.30
Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum Mol Genet (2001) 1.29
Oncogenes and human breast cancer. Am J Hum Genet (1989) 1.29
Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am J Hum Genet (1986) 1.28
High-density genetic map of the BRCA1 region of chromosome 17q12-q21. Genomics (1993) 1.28
Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins. Am J Hum Genet (1997) 1.28
Human genetics and human rights. Identifying the families of kidnapped children. Am J Forensic Med Pathol (1984) 1.27
Practical guide for estimating risk for familial breast cancer. Lancet (1983) 1.26
Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet (1996) 1.23
Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus. Science (1980) 1.21
Human genetics. Sexual orientation and the X. Nature (1993) 1.20
Genetic epidemiology. Annu Rev Public Health (1984) 1.17
Genomic views of human history. Science (1999) 1.16
Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol (1975) 1.15
Genetic analysis of cystic fibrosis: linkage of DNA and classical markers in multiplex families. Am J Hum Genet (1986) 1.15
SeqHelp: a program to analyze molecular sequences utilizing common computational resources. Genome Res (1998) 1.14
Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health (1990) 1.12
PCR detection of an MboI polymorphism in the ERBB2 (HER2; NEU) gene on chromosome 17q11.2-q12. Nucleic Acids Res (1991) 1.12
The search for BRCA1. Cancer Res (1994) 1.11
Environmental and behavioral determinants of fasting plasma glucose in women. A matched co-twin analysis. Am J Epidemiol (1987) 1.05
Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol (1999) 1.03
Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol (1983) 1.02
Chromosome 1 Charcot-Marie-Tooth disease (CMT1B) locus in the Fc gamma receptor gene region. Hum Genet (1991) 1.00
The APCI1307K allele and breast cancer risk. Nat Genet (1998) 0.99
Inherited predisposition to breast and ovarian cancer. Am J Hum Genet (1994) 0.98
Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1. Genomics (1996) 0.98
The influence of social and political violence on the risk of pregnancy complications. Am J Public Health (1992) 0.97
Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum (1999) 0.94
Further characterization of the DFNA1 audiovestibular phenotype. Arch Otolaryngol Head Neck Surg (1998) 0.93
African-American HLA class II allele and haplotype diversity. Tissue Antigens (1997) 0.92
Genetic epidemiology of breast and ovarian cancers. Epidemiol Rev (1997) 0.91
Cholecystokinin cholecystography in the diagnosis of acalculous extrahepatic biliary tract disorders. Am J Gastroenterol (1978) 0.91
Genetic influences on changes in body mass index: a longitudinal analysis of women twins. Obes Res (1997) 0.90
Breast cancer genes: how many, where and who are they? Nat Genet (1992) 0.89
Evidence of genetic influence on central body fat in middle-aged twins. Hum Biol (1989) 0.89
Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. J Natl Cancer Inst (1981) 0.88
Genetic epidemiology of breast cancer: a comment on heterogeneity. Genet Epidemiol (1985) 0.87
Inherited breast cancer: an emerging picture. Clin Genet (1998) 0.87
A novel sodium bicarbonate cotransporter-like gene in an ancient duplicated region: SLC4A9 at 5q31. Genome Biol (2001) 0.86
A functional assay for mutations in tumor suppressor genes caused by mismatch repair deficiency. Hum Mol Genet (2001) 0.86
New data on glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia. G6PD variants, and the association between enzyme deficiency and hemoglobins S. Hum Hered (1977) 0.86
Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet (1999) 0.86
An automated technique for identification and analysis of activation fronts in a two-dimensional electrogram array. Comput Biomed Res (1994) 0.86
Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis. J Natl Cancer Inst (1983) 0.85
Influence of host genotype on progression to AIDS among HIV-infected men. J Acquir Immune Defic Syndr (1991) 0.85
Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer (2000) 0.85
Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. J Pediatr (1995) 0.85
Hardy-Weinberg testing for HLA class II (DRB1, DQA1, DQB1, and DPB1) loci in 26 human ethnic groups. Tissue Antigens (1999) 0.84
Rare HRAS alleles and susceptibility to human breast cancer. Genomics (1990) 0.84
HLA in breast cancer-prone families and the cancer family syndrome. Prog Clin Biol Res (1977) 0.84